6. Revised AEFI Reporting Form
6. Revised AEFI Reporting Form
Clinical Description
Severe Local Reaction Fever > 38° C Redness and swelling at the injection site Injection site abscess
Clinical Information
Anaphylaxis Fits & Seizures Unconsciousness Nausea & Vomiting Diarrhoea Headache Respirator
Swelling of body and face Other What if Other ____________________________________________________
Congenital anomaly / birth defect Persistent or significant disability or disability (paralysis) Life threatening
Hospitalization or prolongation of existing hospitalization (e.g. encephalopathy, seizures aseptic meningitis) Death
Date and Time of onset of symptoms ____/_____/_______ - ___:___ Was the patient hospitalized Yes No , If Ye
Hospital _________________________________________ Address : __________________________________________
Date and Time of hospitalization ____/_____/_______ - ___:___
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
________________________________________________________________________
Past History (including history of similar reaction or other allergies), medication and other relevant information e.g., othe
additional sheet if needed) ____________________________________________________________________________
Recovering Recovered Recovered with sequalae Not Recovered Unknown
Outcome
Adverse Events Following Immunization (AEFI) Investigation Form V.1.0 form developed in July 2024.
Expanded Programme on Immunization (EPI)
Adverse Events Following Immunization (AEFI) Reporting Form
Note: The AEFI case investigation should be initiated within 24 hours of notification . Submit the report to local health facility incharge who will send to CEO/DHO office. All fields
are compulsory/mandatory to be filled. In case of emergency, notify AEFI focal person immediately.
Adverse Events Following Immunization (AEFI) Investigation Form V.1.0 form developed in July 2024.